Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 806-591-9 | CAS number: 175481-37-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian cell study: DNA damage and/or repair
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 16 May 2000 to 25 July 2000
- Reliability:
- 1 (reliable without restriction)
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 000
- Report date:
- 2000
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 486 (Unscheduled DNA Synthesis (UDS) Test with Mammalian Liver Cells in vivo)
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- unscheduled DNA synthesis
Test material
- Reference substance name:
- (R)-2-acetamido-N-benzyl-3-methoxypropionamide
- EC Number:
- 605-756-0
- Cas Number:
- 175481-36-4
- Molecular formula:
- C13H18N2O3
- IUPAC Name:
- (R)-2-acetamido-N-benzyl-3-methoxypropionamide
- Test material form:
- other: Crystalline powder
Constituent 1
- Specific details on test material used for the study:
- batch number KK 02457
Test animals
- Species:
- rat
- Strain:
- other: Fischer (Iffa-Credo)
- Details on species / strain selection:
- Male rats are commonly used in this test and are recommended by the OECD guideline
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: IFFA CREDO origin, Saint-Germain-sur-l'Arbresle FRANCE)
- Age at study initiation: 5 to 6 weeks
- Weight at study initiation: 153 to 208 g
- Assigned to test groups randomly: yes, randomly assigned to the negative, positive control and treatment groups, 3 animals per group.
- Fasting period before study: no
- Housing: polypropylene cages covered by stainless steel netted lid
- Diet (e.g. ad libitum): not stated
- Water :ad libitum):
- Acclimation period: at least 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22+/- 2'C
- Humidity (%): 55+/- 15%
- Air changes (per hr): 12 per hour
- Photoperiod (hrs dark / hrs light): 12/12
IN-LIFE DATES: From: 16 May 2000 To: 25 July 2000
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- 0.5% carboxymethyl cellulose dosed at 10 ml/kg
- Details on exposure:
- PREPARATION OF DOSING SOLUTIONS: The test compound was dissolved in 0.5% carboxymethyl cellulose at 32 mg/mL (preliminary test) or 20 mg/mL (genotoxicity test) and used at a dose volume of 10 ml/kg
- Duration of treatment / exposure:
- single dose with expression times of either 2-4 hours or 12-16 hours after dosing
- Frequency of treatment:
- once
Doses / concentrationsopen allclose all
- Dose / conc.:
- 25 mg/kg bw/day (nominal)
- Remarks:
- 2-acetamidofluorene (positive control)
- Dose / conc.:
- 10 mg/kg bw/day (nominal)
- Remarks:
- Dimethylhydrazine (positive control)
- Dose / conc.:
- 200 mg/kg bw/day (nominal)
- Remarks:
- High dose
- Dose / conc.:
- 100 mg/kg bw/day (nominal)
- Remarks:
- Low dose
- Dose / conc.:
- 0 mg/kg bw/day (nominal)
- No. of animals per sex per dose:
- 4 treated and 3 used for hepatocyte culture per dose
- Control animals:
- yes, concurrent vehicle
- Positive control(s):
- 2-acetylaminofluorene; Dimethylhydrazine
- Justification for choice of positive control(s):
- Route of administration: oral
- Doses / concentrations: 25 and 10 respectively (single doses)
Examinations
- Evaluation criteria:
- For each slide and dose, the following parameters are calculated and presented in tables:
- the average NNG and standard deviation (SD),
- the percent of cells in repair and standard deviation (NNG 5),
- the population average cytoplasmic and nuclear grain count,
- the number of cells in S-phase.
The study would be considered valid if the negative control mean had zero NNG counts or less (i.e. a negative value, within the historical range). The positive control treatments should have values of 5 or more NNG with 50 % or more cells having NNG counts of 5 or greater.
Results and discussion
Test results
- Key result
- Sex:
- male
- Genotoxicity:
- negative
- Remarks:
- Investigation at two expression times (2-4 hours and 12-16 hours) in the in vivo Unscheduled DNA Synthesis (UDS) test in hepatocytes from male Fischer rats, treated orally once at 100 and 200 mg/kg was negative
- Toxicity:
- no effects
- Vehicle controls validity:
- valid
- Negative controls validity:
- valid
- Positive controls validity:
- valid
Applicant's summary and conclusion
- Conclusions:
- The test compound was investigated at two expression times (2-4 hours and 12-16 hours) in the in vivo Unscheduled DNA Synthesis (UDS) test in hepatocytes from male Fischer rats, treated orally once at 100 and 200 mg/kg. As a conclusion, the test item did not reveal any genotoxic activity under these test conditions.
- Executive summary:
The potential genotoxic activity of the test item was tested using the In Vivo Unscheduled DNA Synthesis (UDS) test in rat hepatocytes in compliance with the OECD guideline no. 486.
Preliminary toxicity assay demonstrated that under the test conditions, the maximum tolerated dose of the test compound was 320 mg/kg by oral route, this dose was not retained as the top dose due to the severity of symptoms. Therefore, 200 mg/kg was retained as the top dose for the UDS test. A lower dose of 100 mg/kg was also tested. No mortality was noted in the animals treated at any doses during the UDS assay.
Negative control animals gave a group mean NNG value of less than zero with a percentage of cells in repair comparable with historical control data. In positive controls, group mean net nuclear grain count (NNG) values as well as percentage of cells in repair obtained were within the range of historical control. These values showed the sensitivity of the animal strain used to two DNA damaging agents requiring metabolism for their action, dimethylhydrazine and 2-acetamidofluorene:' Therefore, the validity criteria for the test were fulfilled.
Over the two experiments, group mean net nuclear grain count (NNG) values at the two doses tested (100 or 200 mg/kg) were less than zero (-3.43 to -4.07 for 2-4 hour expression time and -2.86 to -2.18 for 12-16 hour expression time), that is to say below the threshold value 0 NNG for a positive response.
Furthermore, no significant increase in the percentage of cells in repair at any doses tested when compared with the respective controls (2.87 % at 100 mg/kg and 2.42 % at 200 mg/kg vs 2.30 % in control in the 2-4 hour assay and 3.44 % at 100 mg/kg and 5.34 % at 200 mg/kg vs 4.16% in control in the 12-16 hour assay, respectively). In addition, in cells in repair,· group mean net nuclear grain count (NNG;::::5) ·values were comparable with the solvent controls (7.37 at 100 mg/kg to 10.27 at 200 mg/kg vs 6.46 in control in the 2-4 hour assay and 6.65 at 100 mg/kg to 7.38 at 200 mg/kg vs 6.81 in control in the 12-16 hour assay).
Moreover, the frequency of cells in S-phase was low from 0 to 0.1% in animals treated with 100 and 200 mg/kg of the test item in the 12-16 hour assay and from 0.6 to 1.3% in animals treated with 100 and 200 mg/kg in the 2-4 hour assay. It was concluded that the test item did not induce a proliferative effect in rat livers under the experimental conditions employed.
In conclusion, the test compound was investigated at two expression times (2-4 hours and 12-16 hours) in the in vivo Unscheduled DNA Synthesis (UDS) test in hepatocytes from male Fischer rats, treated orally once at 100 and 200 mg/kg. As a conclusion, the test item did not reveal any genotoxic activity under these test conditions.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.